Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: A quantitative proteomics study

Molecular and Cellular Proteomics

Volumn 13, Issue 5, 2014, Pages 1198-1218

  Uzozie, Anuli ^a   Nanni, Paolo ^a   Staiano, Teresa ^b   Grossmann, Jonas ^a   Barkow Oesterreicher, Simon ^a   Shay, Jerry W ^c   Tiwari, Amit ^a   Buffoli, Federico ^b   Laczko, Endre ^a   Marra, Giancarlo ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b CREMONA HOSPITAL   (Italy)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IDITOL DEHYDROGENASE; AKR1B1 PROTEIN, HUMAN; ALDEHYDE REDUCTASE; FRUCTOKINASE; KETOHEXOKINASE; TUMOR MARKER;

ARTICLE; CANCER CELL LINE; CARCINOGENESIS; COLORECTAL ADENOMA; CONTROLLED STUDY; EPITHELIUM CELL; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY; UPREGULATION; ADENOMA; AGED; CACO 2 CELL LINE; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; HT 29 CELL LINE; MALE; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; STOMACH MUCOSA; TUMOR CELL LINE; VERY ELDERLY;

ADENOMA; AGED; AGED, 80 AND OVER; ALDEHYDE REDUCTASE; CACO-2 CELLS; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; COLORECTAL NEOPLASMS; FRUCTOKINASES; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; L-IDITOL 2-DEHYDROGENASE; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84899714616     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.035105     Document Type: Article

References (82)

1. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin. 61, 69-90
2. Siegel, R., Naishadham, D., and Jemal, A. (2013) Cancer statistics, 2013. CA Cancer J. Clin. 63, 11-30
3. Shinya, H., and Wolff, W. I. (1979) Morphology, anatomic distribution and cancer potential of colonic polyps. Ann. Surg. 190, 679-683
4. Cattaneo, E., Baudis, M., Buffoli, F., Bianco, M. A., Zorzi, F., and Marra, G. (2011) Pathways and crossroads to colorectal cancer In Pre-Invasive Disease: Pathogenesis and Clinical Management (Fitzgerald, R. C., ed), pp. 369-394, Springer, New York
5. U.S. Multi-Society Task Force (2002) Screening for colorectal cancer: Recommendation and rationale. Ann. Intern. Med. 137, 129-131
6. Kahi, C. J., Rex, D. K., and Imperiale, T. F. (2008) Screening, surveillance, and primary prevention for colorectal cancer: A review of the recent literature. Gastroenterology 135, 380-399
7. Levin, B., Lieberman, D. A., McFarland, B., Andrews, K. S., Brooks, D., Bond, J., Dash, C., Giardiello, F. M., Glick, S., Johnson, D., Johnson, C. D., Levin, T. R., Pickhardt, P. J., Rex, D. K., Smith, R. A., Thorson, A., Winawer, S. J., American Cancer Society Colorectal Cancer Advisory, U.S. Multi-Society Task Force, and American College of Radiology Colon Cancer (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134, 1570-1595
8. Sillars-Hardebol, A. H., Carvalho, B., Van Engeland, M., Fijneman, R. J., and Meijer, G. A. (2012) The adenoma hunt in colorectal cancer screening: Defining the target. J. Pathol. 226, 1-6
9. de Wit, M., Fijneman, R. J., Verheul, H. M., Meijer, G. A., and Jimenez, C. R. (2013) Proteomics in colorectal cancer translational research: Biomarker discovery for clinical applications. Clin. Biochem. 46, 466-479
10. Patterson, S. D., and Aebersold, R. H. (2003) Proteomics: The first decade and beyond. Nat. Genet. 33 Suppl, 311-323
11. Horth, P., Miller, C. A., Preckel, T., and Wenz, C. (2006) Efficient fractionation and improved protein identification by peptide OFFGEL electrophoresis. Mol. Cell. Proteomics 5, 1968-1974
12. Wu, W. W., Wang, G., Baek, S. J., and Shen, R. F. (2006) Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel or LC-MALDI TOF/TOF. J. Proteome Res. 5, 651-658
13. Aebersold, R., and Mann, M. (2003) Mass spectrometry-based proteomics. Nature 422, 198-207
14. Aebersold, R., and Goodlett, D. R. (2001) Mass spectrometry in proteomics. Chem. Rev. 101, 269-295
15. Bensimon, A., Heck, A. J., and Aebersold, R. (2012) Mass spectrometrybased proteomics and network biology. Annu. Rev. Biochem. 81, 379-405
16. Bantscheff, M., Lemeer, S., Savitski, M. M., and Kuster, B. (2012) Quantitative mass spectrometry in proteomics: Critical review update from 2007 to the present. Anal. Bioanal. Chem. 404, 939-965
17. Wiese, S., Reidegeld, K. A., Meyer, H. E., and Warscheid, B. (2007) Protein labeling by iTRAQ: A new tool for quantitative mass spectrometry in proteome research. Proteomics 7, 340-350
18. Gan, C. S., Chong, P. K., Pham, T. K., and Wright, P. C. (2007) Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). J. Proteome Res. 6, 821-827
19. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., Jacobson, A., and Pappin, D. J. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3, 1154-1169
20. Jimenez, C. R., Knol, J. C., Meijer, G. A., and Fijneman, R. J. (2010) Proteomics of colorectal cancer: Overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. J. Proteomics 73, 1873-1895
21. Besson, D., Pavageau, A. H., Valo, I., Bourreau, A., Belanger, A., Eymerit-Morin, C., Mouliere, A., Chassevent, A., Boisdron-Celle, M., Morel, A., Solassol, J., Campone, M., Gamelin, E., Barre, B., Coqueret, O., and Guette, C. (2011) A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. Mol. Cell. Proteomics 10, M111.009712
22. Jankova, L., Chan, C., Fung, C. L., Song, X., Kwun, S. Y., Cowley, M. J., Kaplan, W., Dent, O. F., Bokey, E. L., Chapuis, P. H., Baker, M. S., Robertson, G. R., Clarke, S. J., and Molloy, M. P. (2011) Proteomic comparison of colorectal tumours and non-neoplastic mucosa from paired patient samples using iTRAQ mass spectrometry. Mol. Biosyst. 7, 2997-3005
23. Roig, A. I., Eskiocak, U., Hight, S. K., Kim, S. B., Delgado, O., Souza, R. F., Spechler, S. J., Wright, W. E., and Shay, J. W. (2010) Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro. Gastroenterology 138, 1012-1021
24. Kall, L., Storey, J. D., MacCoss, M. J., and Noble, W. S. (2008) Posterior error probabilities and false discovery rates: Two sides of the same coin. J. Proteome Res. 7, 40-44
25. Alexa, A., Rahnenfuhrer, J., and Lengauer, T. (2006) Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22, 1600-1607
26. Cattaneo, E., Laczko, E., Buffoli, F., Zorzi, F., Bianco, M. A., Menigatti, M., Bartosova, Z., Haider, R., Helmchen, B., Sabates-Bellver, J., Tiwari, A., Jiricny, J., and Marra, G. (2011) Preinvasive colorectal lesion transcriptomes correlate with endoscopic morphology (polypoid vs. nonpolypoid). EMBO Mol. Med. 3, 334-347
27. Truninger, K., Menigatti, M., Luz, J., Russell, A., Haider, R., Gebbers, J. O., Bannwart, F., Yurtsever, H., Neuweiler, J., Riehle, H. M., Cattaruzza, M. S., Heinimann, K., Scha?r, P., Jiricny, J., and Marra, G. (2005) Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology 128, 1160-1171
28. Gerlach, U., and Hilby, W. (1974) Methods of Enzymatic Analysis, 2nd Ed., Academic Press Inc., New York
29. Lisec, J., Schauer, N., Kopka, J., Willmitzer, L., and Fernie, A. R. (2006) Gas chromatography mass spectrometry-based metabolite profiling in plants. Nat. Protoc. 1, 387-396
30. Afkarian, M., Bhasin, M., Dillon, S. T., Guerrero, M. C., Nelson, R. G., Knowler, W. C., Thadhani, R., and Libermann, T. A. (2010) Optimizing a proteomics platform for urine biomarker discovery. Mol. Cell. Proteomics 9, 2195-2204
31. Ishihama, Y., Oda, Y., Tabata, T., Sato, T., Nagasu, T., Rappsilber, J., and Mann, M. (2005) Exponentially modified protein abundance index (em-PAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics 4, 1265-1272
32. Maglietta, R., Liuzzi, V. C., Cattaneo, E., Laczko, E., Piepoli, A., Panza, A., Carella, M., Palumbo, O., Staiano, T., Buffoli, F., Andriulli, A., Marra, G., and Ancona, N. (2012) Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon. BMC Cancer 12, 608
33. Ow, S. Y., Salim, M., Noirel, J., Evans, C., Rehman, I., and Wright, P. C. (2009) iTRAQ underestimation in simple and complex mixtures: ?the good, the bad and the ugly.? J. Proteome Res. 8, 5347-5355
34. Albrethsen, J., Knol, J. C., Piersma, S. R., Pham, T. V., de Wit, M., Mongera, S., Carvalho, B., Verheul, H. M., Fijneman, R. J., Meijer, G. A., and Jimenez, C. R. (2010) Subnuclear proteomics in colorectal cancer: Identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression. Mol. Cell. Proteomics 9, 988-1005
35. Lam, F., Jankova, L., Dent, O. F., Molloy, M. P., Kwun, S. Y., Clarke, C., Chapuis, P., Robertson, G., Beale, P., Clarke, S., Bokey, E. L., and Chan, C. (2010) Identification of distinctive protein expression patterns in colorectal adenoma. Proteomics Clin. Appl. 4, 60-70
36. Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., Zwahlen, M., Kampf, C., Wester, K., Hober, S., Wernerus, H., Bjorling, L., and Ponten, F. (2010) Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248-1250
37. Park, J. E., Lee, D. H., Lee, J. A., Park, S. G., Kim, N. S., Park, B. C., and Cho, S. (2005) Annexin A3 is a potential angiogenic mediator. Biochem. Biophys. Res. Commun. 337, 1283-1287
38. Gerke, V., Creutz, C. E., and Moss, S. E. (2005) Annexins: Linking Ca2- signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 6, 449-461
39. Duncan, R., Carpenter, B., Main, L. C., Telfer, C., and Murray, G. I. (2008) Characterisation and protein expression profiling of annexins in colorectal cancer. Br. J. Cancer 98, 426-433
40. Mussunoor, S., and Murray, G. I. (2008) The role of annexins in tumour development and progression. J. Pathol. 216, 131-140
41. Melle, C., Ernst, G., Schimmel, B., Bleul, A., Mothes, H., Kaufmann, R., Settmacher, U., and Von Eggeling, F. (2006) Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma. Int. J. Oncol. 28, 195-200
42. Lewit-Bentley, A., Rety, S., Sopkova-de Oliveira Santos, J., and Gerke, V. (2000) S100-annexin complexes: Some insights from structural studies. Cell Biol. Int. 24, 799-802
43. Donato, R. (2001) S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668
44. Thangaraju, M., Carswell, K. N., Prasad, P. D., and Ganapathy, V. (2009) Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3. Biochem. J. 417, 379-389
45. Thorn, C. C., Freeman, T. C., Scott, N., Guillou, P. J., and Jayne, D. G. (2009) Laser microdissection expression profiling of marginal edges of colorectal tumours reveals evidence of increased lactate metabolism in the aggressive phenotype. Gut 58, 404-412
46. Fan, J., Hitosugi, T., Chung, T. W., Xie, J., Ge, Q., Gu, T. L., Polakiewicz, R. D., Chen, G. Z., Boggon, T. J., Lonial, S., Khuri, F. R., Kang, S., and Chen, J. (2011) Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(-) redox homeostasis in cancer cells. Mol. Cell. Biol. 31, 4938-4950
47. Koppenol, W. H., Bounds, P. L., and Dang, C. V. (2011) Otto Warburg?s contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 11, 325-337
48. Reynolds, A., Parris, A., Evans, L. A., Lindqvist, S., Sharp, P., Lewis, M., Tighe, R., and Williams, M. R. (2007) Dynamic and differential regulation of NKCC1 by calcium and cAMP in the native human colonic epithelium. J. Physiol. 582, 507-524
49. Flagella, M., Clarke, L. L., Miller, M. L., Erway, L. C., Giannella, R. A., Andringa, A., Gawenis, L. R., Kramer, J., Duffy, J. J., Doetschman, T., Lorenz, J. N., Yamoah, E. N., Cardell, E. L., and Shull, G. E. (1999) Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf. J. Biol. Chem. 274, 26946-26955
50. Schneider, R., Bannister, A. J., Weise, C., and Kouzarides, T. (2004) Direct binding of INHAT to H3 tails disrupted by modifications. J. Biol. Chem. 279, 23859-23862
51. Kutney, S. N., Hong, R., Macfarlan, T., and Chakravarti, D. (2004) A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression. J. Biol. Chem. 279, 30850-30855
52. Seo, S. B., McNamara, P., Heo, S., Turner, A., Lane, W. S., and Chakravarti, D. (2001) Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 104, 119-130
53. Kondo, Y., and Issa, J. P. (2004) Epigenetic changes in colorectal cancer. Cancer Metastasis Rev. 23, 29-39
54. Kondo, Y., Shen, L., and Issa, J. P. (2003) Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol. Cell. Biol. 23, 206-215
55. Ouellet, V., Le Page, C., Guyot, M. C., Lussier, C., Tonin, P. N., Provencher, D. M., and Mes-Masson, A. M. (2006) SET complex in serous epithelial ovarian cancer. Int. J. Cancer 119, 2119-2126
56. Takahashi, K., Inuzuka, M., and Ingi, T. (2004) Cellular signaling mediated by calphoglin-induced activation of IPP and PGM. Biochem. Biophys. Res. Commun. 325, 203-214
57. Lapeyre, B., Bourbon, H., and Amalric, F. (1987) Nucleolin, the major nucleolar protein of growing eukaryotic cells: An unusual protein structure revealed by the nucleotide sequence. Proc. Natl. Acad. Sci. U.S.A. 84, 1472-1476
58. Ginisty, H., Amalric, F., and Bouvet, P. (1998) Nucleolin functions in the first step of ribosomal RNA processing. EMBO J. 17, 1476-1486
59. Ginisty, H., Sicard, H., Roger, B., and Bouvet, P. (1999) Structure and functions of nucleolin. J. Cell Sci. 112 (Pt 6), 761-772
60. Tajrishi, M. M., Tuteja, R., and Tuteja, N. (2011) Nucleolin: The most abundant multifunctional phosphoprotein of nucleolus. Commun. Integr. Biol. 4, 267-275
61. Chien, J., Fan, J. B., Bell, D. A., April, C., Klotzle, B., Ota, T., Lingle, W. L., Gonzalez Bosquet, J., Shridhar, V., and Hartmann, L. C. (2009) Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer. Gynecol. Oncol. 114, 3-11
62. Ishiyama, T., Kano, J., Anami, Y., Onuki, T., Iijima, T., Morisita, Y., Yokota, J., and Noguchi, M. (2007) OCIA domain containing 2 is highly expressed in adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component and is associated with better prognosis. Cancer Sci. 98, 50-57
63. Nagata, C., Kobayashi, H., Sakata, A., Satomi, K., Minami, Y., Morishita, Y., Ohara, R., Yoshikawa, H., Arai, Y., Nishida, M., and Noguchi, M. (2012) Increased expression of OCIA domain containing 2 during stepwise progression of ovarian mucinous tumor. Pathol. Int. 62, 471-476
64. Oue, N., Kuniyasu, H., Noguchi, T., Sentani, K., Ito, M., Tanaka, S., Setoyama, T., Sakakura, C., Natsugoe, S., and Yasui, W. (2007) Serum concentration of Reg IV in patients with colorectal cancer: Overexpression and high serum levels of Reg IV are associated with liver metastasis. Oncology 72, 371-380
65. Rafa, L., Dessein, A. F., Devisme, L., Buob, D., Truant, S., Porchet, N., Huet, G., Buisine, M. P., and Lesuffleur, T. (2010) REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells. Int. J. Oncol. 36, 689-698
66. Violette, S., Festor, E., Pandrea-Vasile, I., Mitchell, V., Adida, C., Dussaulx, E., Lacorte, J. M., Chambaz, J., Lacasa, M., and Lesuffleur, T. (2003) Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas. Int. J. Cancer 103, 185-193
67. Obrosova, I. G. (2005) Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications. Antioxid. Redox Signal. 7, 1543-1552
68. Ola, M. S., Berkich, D. A., Xu, Y., King, M. T., Gardner, T. W., Simpson, I., and LaNoue, K. F. (2006) Analysis of glucose metabolism in diabetic rat retinas. Am. J. Physiol. Endocrinol. Metab. 290, E1057-E1067
69. Van Den Enden, M. K., Nyengaard, J. R., Ostrow, E., Burgan, J. H., and Williamson, J. R. (1995) Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Implications for diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 36, 1675-1685
70. Gabbay, K. H., Merola, L. O., and Field, R. A. (1966) Sorbitol pathway: Presence in nerve and cord with substrate accumulation in diabetes. Science 151, 209-210
71. Hwang, Y. C., Bakr, S., Ellery, C. A., Oates, P. J., and Ramasamy, R. (2003) Sorbitol dehydrogenase: A novel target for adjunctive protection of ischemic myocardium. FASEB J. 17, 2331-2333
72. Szabo, Z., Hamalainen, J., Loikkanen, I., Moilanen, A. M., Hirvikoski, P., Vaisanen, T., Paavonen, T. K., and Vaarala, M. H. (2010) Sorbitol dehydrogenase expression is regulated by androgens in the human prostate. Oncol. Rep. 23, 1233-1239
73. Obrosova, I. G. (2005) Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications. Antioxid. Redox Signal. 7, 1543-1552
74. Dills, W. L., Jr. (1993) Protein fructosylation: Fructose and the Maillard reaction. Am. J. Clin. Nutr. 58, 779S-787S
75. Suarez, G., Rajaram, R., Oronsky, A. L., and Gawinowicz, M. A. (1989) Nonenzymatic glycation of bovine serum albumin by fructose (fructation). Comparison with the Maillard reaction initiated by glucose. J. Biol. Chem. 264, 3674-3679
76. Schalkwijk, C. G., Stehouwer, C. D., and Van Hinsbergh, V. W. (2004) Fructose-mediated non-enzymatic glycation: Sweet coupling or bad modification. Diabetes Metab. Res. Rev. 20, 369-382
77. Bose, T., and Chakraborti, A. S. (2008) Fructose-induced structural and functional modifications of hemoglobin: Implication for oxidative stress in diabetes mellitus. Biochim. Biophys. Acta 1780, 800-808
78. Schmidt, A. M., Hori, O., Brett, J., Yan, S. D., Wautier, J. L., and Stern, D. (1994) Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler. Thromb. 14, 1521-1528
79. Warburg, O. (1956) On the origin of cancer cells. Science 123, 309-314
80. Chan, E. C., Koh, P. K., Mal, M., Cheah, P. Y., Eu, K. W., Backshall, A., Cavill, R., Nicholson, J. K., and Keun, H. C. (2009) Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J. Proteome Res. 8, 352-361
81. Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshita, T., Saito, N., Ochiai, A., Tomita, M., Esumi, H., and Soga, T. (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69, 4918-4925
82. Kudo, S., Rubio, C. A., Teixeira, C. R., Kashida, H., Kogure, E. et al. (2001) Pit pattern in colorectal neoplasia: Endoscopic magnifying view. Endoscopy 33, 367